- 期刊
Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study
延伸閱讀
- Selaas, O., Nordal, H. H., Halse, A. K., Brun, J. G., Jonsson, R., & Brokstad, K. A. (2015). Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment. International Journal of Rheumatology, 2015(), 30-38. https://doi.org/10.1155/2015/276815
- Kanbe, K., Chiba, J., Inoue, Y., Taguchi, M., Yabuki, A., & Deguchi, T. (2016). Simultaneous Treatment with Subcutaneous Injection of Golimumab and Intra-articular Injection of Triamcinolone Acetonide (K-Method) in Patients with Rheumatoid Arthritis Undergoing Switching of Biologics: Retrospective Case-Control Study. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, (2016), 45-49. https://doi.org/10.4137/CMAMD.S38442
- Ogata, A., & Tanaka, T. (2012). Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions. International Journal of Rheumatology, 2012(), 353-366. https://doi.org/10.1155/2012/946048
- Jilani, A. A., & Young, C. G. M. (2015). The Role of Citrullinated Protein Antibodies in Predicting Erosive Disease in Rheumatoid Arthritis: A Systematic Literature Review and Meta-Analysis. International Journal of Rheumatology, 2015(), 83-90. https://doi.org/10.1155/2015/728610
- Meyer, P. W. A., Hodkinson, B., Ally, M., Musenge, E., Wadee, A. A., Fickl, H., Tikly, M., & Anderson, R. (2010). Circulating Cytokine Profiles and Their Relationships with Autoantibodies, Acute Phase Reactants, and Disease Activity in Patients with Rheumatoid Arthritis. Mediators of Inflammation, 2010(), 61-70. https://doi.org/10.1155/2010/158514